| 000 | 01848 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515023719.0 | ||
| 264 | 0 | _c20060719 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a0006-291X | ||
| 024 | 7 |
_a10.1016/j.bbrc.2006.03.241 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHusmann, Matthias | |
| 245 | 0 | 0 |
_aDifferential role of p38 mitogen activated protein kinase for cellular recovery from attack by pore-forming S. aureus alpha-toxin or streptolysin O. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cJun 2006 |
||
| 300 |
_a1128-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
| 650 | 0 | 4 |
_aBacterial Proteins _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Toxins _xpharmacology |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 | _aCell Membrane Permeability |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aHemolysin Proteins |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKeratinocytes _xdrug effects |
| 650 | 0 | 4 |
_aMAP Kinase Kinase Kinase 5 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStaphylococcus aureus |
| 650 | 0 | 4 |
_aStreptolysins _xpharmacology |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 700 | 1 | _aDersch, Katrin | |
| 700 | 1 | _aBobkiewicz, Wiesia | |
| 700 | 1 | _aBeckmann, Erik | |
| 700 | 1 | _aVeerachato, Gunnaporn | |
| 700 | 1 | _aBhakdi, Sucharit | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 344 _gno. 4 _gp. 1128-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2006.03.241 _zAvailable from publisher's website |
| 999 |
_c16246505 _d16246505 |
||